Cargando…
PKR: A Kinase to Remember
Aging is a major risk factor for many diseases including metabolic syndrome, cancer, inflammation, and neurodegeneration. Identifying mechanistic common denominators underlying the impact of aging is essential for our fundamental understanding of age-related diseases and the possibility to propose n...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333748/ https://www.ncbi.nlm.nih.gov/pubmed/30686999 http://dx.doi.org/10.3389/fnmol.2018.00480 |
_version_ | 1783387613762158592 |
---|---|
author | Gal-Ben-Ari, Shunit Barrera, Iliana Ehrlich, Marcelo Rosenblum, Kobi |
author_facet | Gal-Ben-Ari, Shunit Barrera, Iliana Ehrlich, Marcelo Rosenblum, Kobi |
author_sort | Gal-Ben-Ari, Shunit |
collection | PubMed |
description | Aging is a major risk factor for many diseases including metabolic syndrome, cancer, inflammation, and neurodegeneration. Identifying mechanistic common denominators underlying the impact of aging is essential for our fundamental understanding of age-related diseases and the possibility to propose new ways to fight them. One can define aging biochemically as prolonged metabolic stress, the innate cellular and molecular programs responding to it, and the new stable or unstable state of equilibrium between the two. A candidate to play a role in the process is protein kinase R (PKR), first identified as a cellular protector against viral infection and today known as a major regulator of central cellular processes including mRNA translation, transcriptional control, regulation of apoptosis, and cell proliferation. Prolonged imbalance in PKR activation is both affected by biochemical and metabolic parameters and affects them in turn to create a feedforward loop. Here, we portray the central role of PKR in transferring metabolic information and regulating cellular function with a focus on cancer, inflammation, and brain function. Later, we integrate information from open data sources and discuss current knowledge and gaps in the literature about the signaling cascades upstream and downstream of PKR in different cell types and function. Finally, we summarize current major points and biological means to manipulate PKR expression and/or activation and propose PKR as a therapeutic target to shift age/metabolic-dependent undesired steady states. |
format | Online Article Text |
id | pubmed-6333748 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63337482019-01-25 PKR: A Kinase to Remember Gal-Ben-Ari, Shunit Barrera, Iliana Ehrlich, Marcelo Rosenblum, Kobi Front Mol Neurosci Neuroscience Aging is a major risk factor for many diseases including metabolic syndrome, cancer, inflammation, and neurodegeneration. Identifying mechanistic common denominators underlying the impact of aging is essential for our fundamental understanding of age-related diseases and the possibility to propose new ways to fight them. One can define aging biochemically as prolonged metabolic stress, the innate cellular and molecular programs responding to it, and the new stable or unstable state of equilibrium between the two. A candidate to play a role in the process is protein kinase R (PKR), first identified as a cellular protector against viral infection and today known as a major regulator of central cellular processes including mRNA translation, transcriptional control, regulation of apoptosis, and cell proliferation. Prolonged imbalance in PKR activation is both affected by biochemical and metabolic parameters and affects them in turn to create a feedforward loop. Here, we portray the central role of PKR in transferring metabolic information and regulating cellular function with a focus on cancer, inflammation, and brain function. Later, we integrate information from open data sources and discuss current knowledge and gaps in the literature about the signaling cascades upstream and downstream of PKR in different cell types and function. Finally, we summarize current major points and biological means to manipulate PKR expression and/or activation and propose PKR as a therapeutic target to shift age/metabolic-dependent undesired steady states. Frontiers Media S.A. 2019-01-09 /pmc/articles/PMC6333748/ /pubmed/30686999 http://dx.doi.org/10.3389/fnmol.2018.00480 Text en Copyright © 2019 Gal-Ben-Ari, Barrera, Ehrlich and Rosenblum. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Gal-Ben-Ari, Shunit Barrera, Iliana Ehrlich, Marcelo Rosenblum, Kobi PKR: A Kinase to Remember |
title | PKR: A Kinase to Remember |
title_full | PKR: A Kinase to Remember |
title_fullStr | PKR: A Kinase to Remember |
title_full_unstemmed | PKR: A Kinase to Remember |
title_short | PKR: A Kinase to Remember |
title_sort | pkr: a kinase to remember |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333748/ https://www.ncbi.nlm.nih.gov/pubmed/30686999 http://dx.doi.org/10.3389/fnmol.2018.00480 |
work_keys_str_mv | AT galbenarishunit pkrakinasetoremember AT barrerailiana pkrakinasetoremember AT ehrlichmarcelo pkrakinasetoremember AT rosenblumkobi pkrakinasetoremember |